Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
Clinical trial NCT02808494 · COMPLETED
Trial details
- NCT number
- NCT02808494
- Sponsor
- Illumina, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-11-20
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.